Enovis Launches Hybrid Scoliosis Brace Aimed at Improving Patient Compliance

Event summary

  • Enovis launched the Spinamic® Hybrid Scoliosis Brace on June 8, 2026, combining rigid corrective performance with dynamic wearability.
  • The brace is available in 10 off-the-shelf sizes with an adjustable three-point pressure system for single-visit fitting and adjustment.
  • Spinamic is currently available in the U.S., with regulatory clearance being pursued in additional global markets.
  • Clinical evidence supports the brace's effectiveness in preventing curve progression in adolescent idiopathic scoliosis (AIS).

The big picture

Enovis' Spinamic brace addresses a critical gap in scoliosis treatment by balancing corrective efficacy with patient comfort, a strategic move in an industry increasingly focused on patient-centric solutions. The launch aligns with broader trends in medical technology toward hybrid devices that improve compliance and outcomes. Success will hinge on regulatory expansion and clinical validation in a market where adolescent compliance remains a significant challenge.

What we're watching

Regulatory Momentum
The pace at which Enovis secures regulatory approvals in international markets will determine the global scalability of Spinamic.
Market Adoption
Whether Spinamic can capture significant market share depends on its ability to demonstrate superior patient compliance and clinical outcomes.
Competitive Differentiation
How Enovis positions Spinamic against traditional rigid and dynamic braces will shape its competitive advantage in the scoliosis treatment space.